免疫蛋白酶体抑制诱导浆细胞凋亡并保护移植肾
本研究在大鼠肾移植模型中证实,免疫蛋白酶体抑制剂ONX 0914或广谱蛋白酶体抑制剂硼替佐米均可长期减少同种抗体产生并改善移植肾组织学。ONX 0914通过蓄积泛素结合物、激活未折叠蛋白反应诱导浆细胞凋亡,并抑制骨髓中浆细胞存活因子与黏附分子表达,从而阻断同种抗体产生。
要点
- 免疫蛋白酶体抑制可诱导浆细胞凋亡,减少同种抗体产生
- ONX 0914与硼替佐米均改善大鼠移植肾长期组织学
- 骨髓微环境中浆细胞存活因子与趋化因子被抑制
核心结论
- 免疫蛋白酶体抑制通过激活未折叠蛋白反应并抑制骨髓浆细胞存活因子,诱导浆细胞凋亡,从而阻断同种抗体产生。
研究设计与样本
- 大鼠肾移植模型研究,比较ONX 0914与广谱蛋白酶体抑制剂硼替佐米的长期效应。
主要发现
- ONX 0914或硼替佐米治疗的大鼠出现同种抗体产生长期减少及移植肾组织学改善。
- 移植大鼠浆细胞高表达免疫蛋白酶体,ONX 0914处理后浆细胞内泛素结合物蓄积、未折叠蛋白反应激活并发生凋亡。
- ONX 0914抑制骨髓中黏附分子VLA-4与LFA-1、浆细胞存活因子APRIL与IL-6及IFN-γ诱导趋化因子的表达。
- 浆细胞表面APRIL受体BCMA、IL-6受体及趋化因子受体CXCR4与CXCR3下调。
临床怎么用
- 提示免疫蛋白酶体抑制可能成为靶向浆细胞、防治慢性抗体介导排斥的潜在策略,尚需临床验证。
局限性
- 证据来自大鼠模型,机制与疗效尚未在人体研究中确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic antibody-mediated rejection is the leading cause of allograft dysfunction and loss after kidney transplantation, and current immunosuppressive regimens fail to target the plasma cells that produce alloantibodies. We previously showed that treatment with the immunoproteasome inhibitor ONX 0914 prevented the expansion of plasma cells and prevented chronic allograft nephropathy and organ failure after kidney transplantation in rats, but the mechanism has remained elusive. In the current study, we confirmed a long-term reduction in alloantibody production and improvements in allograft histology in rats treated with ONX 0914 or with the broad-spectrum proteasome inhibitor bortezomib. Plasma cells from allotransplanted rats expressed immunoproteasomes at high levels. Immunoproteasome inhibition with ONX 0914 led to ubiquitin-conjugate accumulation, activation of the unfolded protein response, and induction of apoptosis in plasma cells. In addition, ONX 0914 suppressed the expression of adhesion molecules (VLA-4 and LFA-1), plasma cell survival factors (APRIL and IL-6), and IFN-γ-inducible chemokines in bone marrow, while the APRIL receptor BCMA, the IL-6 receptor, and the chemokine receptors CXCR4 and CXCR3 were down-regulated on plasma cells. Taken together, immunoproteasome inhibition blocked alloantibody production by inducing apoptosis of plasma cells through activating the unfolded protein response and suppressing plasma cell survival factors in the bone marrow.
引用
- Li J, Koerner J, Basler M, et al. Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors. Kidney Int. 2019. PMID: 30685098. doi:10.1016/j.kint.2018.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。